Leptin in joint and bone diseases: New insights

Current Medicinal Chemistry

Volumn 20, Issue 27, 2013, Pages 3416-3425

  Scotece, M ^a   Conde, J ^a   Lopez, V ^a   Lago, F ^a   Pino, J ^b   Gomez Reino, J J ^a   Gualillo, O ^a  

^a Santiago University Clinical Hospital   (Spain)

^b University Hospital of Santiago de Compostela   (Spain)

Author keywords

Bone; Cartilage; Chondrocyte; Inflammation; Leptin; Rheumatic diseases; Synovium

Indexed keywords

AMYLIN; GAMMA INTERFERON; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; LEPTIN; LEPTIN RECEPTOR; METRELEPTIN; PRAMLINTIDE; RECOMBINANT LEPTIN; RECOMBINANT METHYONIL; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ARTHROPATHY; BODY MASS; BONE DENSITY; BONE DISEASE; BONE MASS; CARTILAGE CELL; CLINICAL TRIAL (TOPIC); CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; IMMUNOSTIMULATION; LEPTIN DEFICIENCY; NONHUMAN; OBESITY; OSTEOARTHRITIS; OSTEOBLAST; OSTEOPOROSIS; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SUBSTITUTION THERAPY; SYNOVIUM;

EID: 84883302566     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320270006     Document Type: Review

References (92)

1. Zhang, Y.;Proenca, R.;Maffei, M.;Barone, M.;Leopold, L.;Friedman, J.M. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372(6505), 425-432.
2. Fantuzzi, G., Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol., 2005, 115(5), 911-919.
3. Lago, F.;Dieguez, C.;Gomez-Reino, J.;Gualillo, O. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev., 2007, 18(3-4), 313-325.
4. Flier, J.S. Clinical review 94: What's in a name? In search of leptin's physiologic role. J. Clin. Endocrinol. Metab., 1998, 83(5), 1407-1413.
5. Heymsfield, S.B.;Greenberg, A.S.;Fujioka, K.;Dixon, R.M.;Kushner, R.;Hunt, T.;Lubina, J.A.;Patane, J.;Self, B.;Hunt, P.;McCamish, M. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA, 1999, 282(16), 1568-1575.
6. Roos, C.F.;Chwalla, M.;Kim, K.;Riebe, M.;Blatt, R. 'Designer atoms' for quantum metrology. Nature, 2006, 443(7109), 316-319.
7. Ahima, R.S.;Flier, J.S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab., 2000, 11(8), 327-332.
8. Chilliard, Y.;Bonnet, M.;Delavaud, C.;Faulconnier, Y.;Leroux, C.;Djiane, J.;Bocquier, F. Leptin in ruminants. Gene expression in adipose tissue and mammary gland, and regulation of plasma concentration. Domest. Anim. Endocrinol., 2001, 21(4), 271-295.
9. Otero, M.;Lago, R.;Gomez, R.;Lago, F.;Dieguez, C.;Gomez-Reino, J.J.;Gualillo, O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann. Rheum. Dis., 2006, 65(9), 1198-1201.
10. Sinha, M.K.;Sturis, J.;Ohannesian, J.;Magosin, S.;Stephens, T.;Heiman, M.L.;Polonsky, K.S.;Caro, J.F. Ultradian oscillations of leptin secretion in humans. Biochem. Biophys. Res. Commun., 1996, 228(3), 733-738.
11. Ghilardi, N.;Skoda, R.C. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. Mol. Endocrinol., 1997, 11(4), 393-399.
12. Bahrenberg, G.;Behrmann, I.;Barthel, A.;Hekerman, P.;Heinrich, P.C.;Joost, H.G.;Becker, W. Identification of the critical sequence elements in the cytoplasmic domain of leptin receptor isoforms required for Janus kinase/signal transducer and activator of transcription activation by receptor heterodimers. Mol. Endocrinol., 2002, 16(4),859-872.
13. White, D.W.;Kuropatwinski, K.K.;Devos, R.;Baumann, H.;Tartaglia, L.A., Leptin receptor (OB-R) signaling. Cytoplasmic domain mutational analysis and evidence for receptor homo-oligomerization. J. Biol. Chem., 1997, 272(7), 4065-4071.
14. Devos, R.;Guisez, Y.;Van der Heyden, J.;White, D.W.;Kalai, M.;Fountoulakis, M.;Plaetinck, G. Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding. J. Biol. Chem., 1997, 272(29), 18304-18310.
15. Banks, A.S.;Davis, S.M.;Bates, S.H.;Myers, M.G., Jr. Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem., 2000, 275(19), 14563-14572.
16. Bjorbaek, C.;Uotani, S.;da Silva, B.;Flier, J.S. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J. Biol. Chem., 1997, 272(51), 32686-32695.
17. Gualillo, O.;Eiras, S.;White, D.W.;Dieguez, C.;Casanueva, F.F. Leptin promotes the tyrosine phosphorylation of SHC proteins and SHC association with GRB2. Mol. Cell. Endocrinol., 2002, 190(1-2), 83-89.
18. Niswender, K.D.;Morton, G.J.;Stearns, W.H.;Rhodes, C.J.;Myers, M.G., Jr.;Schwartz, M.W. Intracellular signalling. Key enzyme in leptin-induced anorexia. Nature, 2001, 413(6858), 794-5.
19. Akasaka, Y.;Tsunoda, M.;Ogata, T.;Ide, T.;Murakami, K. Direct evidence for leptin-induced lipid oxidation independent of longform leptin receptor. Biochim. Biophys. Acta, 2010, 1801(10), 1115-1122.
20. Belgardt, B.F.;Husch, A.;Rother, E.;Ernst, M.B.;Wunderlich, F.T.;Hampel, B.;Klockener, T.;Alessi, D.;Kloppenburg, P.;Bruning, J.C. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response. Cell Metab., 2008, 7(4), 291-301.
21. Oswal, A.;Yeo, G. Leptin and the control of body weight: a review of its diverse central targets, signaling mechanisms, and role in the pathogenesis of obesity. Obesity (Silver Spring), 2010, 18(2), 221-229.
22. Reid, I.R. Fat and bone. Arch. Biochem. Biophys., 2010, 503(1), 20-27.
23. Gomez-Ambrosi, J.;Rodriguez, A.;Catalan, V.;Fruhbeck, G. The bone-adipose axis in obesity and weight loss. Obes. Surg., 2008, 18(9), 1134-1143.
24. Shapses, S.A.;Sukumar, D. Bone metabolism in obesity and weight loss. Annu. Rev. Nutr., 2012, 32, 287-309.
25. Ambati, S.;Li, Q.;Rayalam, S.;Hartzell, D.L.;Della-Fera, M.A.;Hamrick, M.W.;Baile, C.A. Central leptin versus ghrelin: effects on bone marrow adiposity and gene expression. Endocrine, 2010, 37(1), 115-123.
26. Ducy, P.;Amling, M.;Takeda, S.;Priemel, M.;Schilling, A.F.;Beil, F.T.;Shen, J.;Vinson, C.;Rueger, J.M.;Karsenty, G. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell, 2000, 100(2), 197-207.
27. Takeda, S.;Elefteriou, F.;Levasseur, R.;Liu, X.;Zhao, L.;Parker, K.L.;Armstrong, D.;Ducy, P.;Karsenty, G. Leptin regulates bone formation via the sympathetic nervous system. Cell, 2002, 111(3), 305-317.
28. Elefteriou, F.;Ahn, J.D.;Takeda, S.;Starbuck, M.;Yang, X.;Liu, X.;Kondo, H.;Richards, W.G.;Bannon, T.W.;Noda, M.;Clement, K.;Vaisse, C.;Karsenty, G. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature, 2005, 434(7032), 514-520.
29. Balthasar, N.;Coppari, R.;McMinn, J.;Liu, S.M.;Lee, C.E.;Tang, V.;Kenny, C.D.;McGovern, R.A.;Chua, S.C., Jr.;Elmquist, J.K.;Lowell, B.B. Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis. Neuron, 2004, 42(6), 983-991.
30. Pogoda, P.;Egermann, M.;Schnell, J.C.;Priemel, M.;Schilling, A.F.;Alini, M.;Schinke, T.;Rueger, J.M.;Schneider, E.;Clarke, I.;Amling, M. Leptin inhibits bone formation not only in rodents, but also in sheep. J. Bone Miner. Res., 2006, 21(10), 1591-1599.
31. Beil, F.T.;Barvencik, F.;Gebauer, M.;Beil, B.;Pogoda, P.;Rueger, J.M.;Ignatius, A.;Schinke, T.;Amling, M. Effects of increased bone formation on fracture healing in mice. J. Trauma, 2011, 70(4), 857-862.
32. Steppan, C.M.;Crawford, D.T.;Chidsey-Frink, K.L.;Ke, H.;Swick, A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul. Pept., 2000, 92(1-3), 73-78.
33. Cornish, J.;Callon, K.E.;Bava, U.;Lin, C.;Naot, D.;Hill, B.L.;Grey, A.B.;Broom, N.;Myers, D.E.;Nicholson, G.C.;Reid, I.R. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J. Endocrinol., 2002, 175(2), 405-415.
34. Motyl, K.J.;Rosen, C.J. Understanding leptin-dependent regulation of skeletal homeostasis. Biochimie, 2012, 94(10), 2089-2096.
35. Myers, M.G., Jr.;Heymsfield, S.B.;Haft, C.;Kahn, B.B.;Laughlin, M.;Leibel, R.L.;Tschop, M.H.;Yanovski, J.A. Challenges and opportunities of defining clinical leptin resistance. Cell Metab., 2012, 15(2), 150-156.
36. Figenschau, Y.;Knutsen, G.;Shahazeydi, S.;Johansen, O.;Sveinbjornsson, B. Human articular chondrocytes express functional leptin receptors. Biochem. Biophys. Res. Commun., 2001, 287(1), 190-197.
37. Otero, M.;Gomez Reino, J.J.;Gualillo, O. Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferongamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis. Rheum., 2003, 48(2), 404-409.
38. Otero, M.;Lago, R.;Lago, F.;Reino, J.J.;Gualillo, O. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis. Res. Ther., 2005, 7(3), 581-591.
39. Gomez, R.;Scotece, M.;Conde, J.;Gomez-Reino, J.J.;Lago, F.;Gualillo, O. Adiponectin and leptin increase IL-8 production in human chondrocytes. Ann. Rheum. Dis., 2011, 70(11), 2052-2054.
40. Conde, J.;Scotece, M.;Lopez, V.;Gomez, R.;Lago, F.;Pino, J.;Gomez-Reino, J.J.;Gualillo, O. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One, 2012, 7(12), 52533.
41. Li, X.F.;Wang, S.J.;Jiang, L.S.;Dai, L.Y. Stage specific effect of leptin on the expressions of estrogen receptor and extracellular matrix in a model of chondrocyte differentiation. Cytokine, 2013, 61(3), 876-884.
42. Wang, L.;Shao, Y.Y.;Ballock, R.T. Leptin Antagonizes Peroxisome Proliferator-Activated Receptor-gamma Signaling in Growth Plate Chondrocytes. PPAR Res., 2012, 2012, 756198.
43. Liang, J.;Feng, J.;Wu, W.K.;Xiao, J.;Wu, Z.;Han, D.;Zhu, Y.;Qiu, G. Leptin-mediated cytoskeletal remodeling in chondrocytes occurs via the RhoA/ROCK pathway. J. Orthop. Res., 2011, 29(3), 369-374.
44. Ben-Eliezer, M.;Phillip, M.;Gat-Yablonski, G. Leptin regulates chondrogenic differentiation in ATDC5 cell-line through JAK/STAT and MAPK pathways. Endocrine, 2007, 32(2), 235-244.
45. Kishida, Y.;Hirao, M.;Tamai, N.;Nampei, A.;Fujimoto, T.;Nakase, T.;Shimizu, N.;Yoshikawa, H.;Myoui, A. Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone, 2005, 37(5), 607-621.
46. Dumond, H.;Presle, N.;Terlain, B.;Mainard, D.;Loeuille, D.;Netter, P.;Pottie, P. Evidence for a key role of leptin in osteoarthritis. Arthritis. Rheum., 2003, 48(11), 3118-3129.
47. Schaffler, A.;Ehling, A.;Neumann, E.;Herfarth, H.;Tarner, I.;Scholmerich, J.;Muller-Ladner, U.;Gay, S. Adipocytokines in synovial fluid. JAMA, 2003, 290(13), 1709-1710.
48. Presle, N.;Pottie, P.;Dumond, H.;Guillaume, C.;Lapicque, F.;Pallu, S.;Mainard, D.;Netter, P.;Terlain, B. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthritis Cartilage, 2006, 14(7), 690-695.
49. Simopoulou, T.;Malizos, K.N.;Iliopoulos, D.;Stefanou, N.;Papatheodorou, L.;Ioannou, M.;Tsezou, A. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage, 2007, 15(8), 872-883.
50. Bokarewa, M.;Bokarew, D.;Hultgren, O.;Tarkowski, A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann. Rheum. Dis., 2003, 62(10), 952-956.
51. Tong, K.M.;Shieh, D.C.;Chen, C.P.;Tzeng, C.Y.;Wang, S.P.;Huang, K.C.;Chiu, Y.C.;Fong, Y.C.;Tang, C.H. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts. Cell Signal., 2008, 20(8), 1478-1488.
52. Ku, J.H.;Lee, C.K.;Joo, B.S.;An, B.M.;Choi, S.H.;Wang, T.H.;Cho, H.L. Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. Clin. Rheumatol., 2009, 28(12), 1431-1435.
53. Koskinen, A.;Vuolteenaho, K.;Nieminen, R.;Moilanen, T.;Moilanen, E. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin. Exp. Rheumatol., 2011, 29(1), 57-64.
54. Gallagher, J.;Tierney, P.;Murray, P.;O'Brien, M. The infrapatellar fat pad: anatomy and clinical correlations. Knee Surg. Sports Traumatol. Arthrosc., 2005, 13(4), 268-272.
55. Distel, E.;Cadoudal, T.;Durant, S.;Poignard, A.;Chevalier, X.;Benelli, C. The infrapatellar fat pad in knee osteoarthritis: an important source of interleukin-6 and its soluble receptor. Arthritis Rheum., 2009, 60(11), 3374-3377.
56. Hui, W.;Litherland, G.J.;Elias, M.S.;Kitson, G.I.;Cawston, T.E.;Rowan, A.D.;Young, D.A. Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases. Ann. Rheum. Dis., 2012, 71(3), 455-462.
57. Clockaerts, S.;Bastiaansen-Jenniskens, Y.M.;Feijt, C.;De Clerck, L.;Verhaar, J.A.;Zuurmond, A.M.;Stojanovic-Susulic, V.;Somville, J.;Kloppenburg, M.;van Osch, G.J. Cytokine production by infrapatellar fat pad can be stimulated by interleukin 1beta and inhibited by peroxisome proliferator activated receptor alpha agonist. Ann. Rheum. Dis., 2012, 71(6), 1012-1018.
58. Bastiaansen-Jenniskens, Y.M.;Clockaerts, S.;Feijt, C.;Zuurmond, A.M.;Stojanovic-Susulic, V.;Bridts, C.;de Clerck, L.;DeGroot, J.;Verhaar, J.A.;Kloppenburg, M.;van Osch, G.J. Infrapatellar fat pad of patients with end-stage osteoarthritis inhibits catabolic mediators in cartilage. Ann. Rheum. Dis., 2012, 71(2), 288-294.
59. Lee, S.W.;Park, M.C.;Park, Y.B.;Lee, S.K. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol. Int., 2007, 27(6), 537-540.
60. Targonska-Stepniak, B.;Majdan, M.;Dryglewska, M. Leptin serum levels in rheumatoid arthritis patients: relation to disease duration and activity. Rheumatol. Int., 2008, 28(6), 585-591.
61. Targonska-Stepniak, B.;Dryglewska, M.;Majdan, M. Adiponectin and leptin serum concentrations in patients with rheumatoid arthritis. Rheumatol. Int., 2010, 30(6), 731-737.
62. Olama, S.M.;Senna, M.K.;Elarman, M. Synovial/serum leptin ratio in rheumatoid arthritis: the association with activity and erosion. Rheumatol. Int., 2012, 32(3), 683-690.
63. Rho, Y.H.;Solus, J.;Sokka, T.;Oeser, A.;Chung, C.P.;Gebretsadik, T.;Shintani, A.;Pincus, T.;Stein, C.M. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum., 2009, 60(7), 1906-1914.
64. Procaccini, C.;Carbone, F.;Galgani, M.;La Rocca, C.;De Rosa, V.;Cassano, S.;Matarese, G. Obesity and susceptibility to autoimmune diseases. Expert Rev. Clin. Immunol., 2011, 7(3), 287-294.
65. Notley, C.A.;Ehrenstein, M.R. The yin and yang of regulatory T cells and inflammation in RA. Nat. Rev. Rheumatol., 2010, 6(10), 572-577.
66. De Rosa, V.;Procaccini, C.;Cali, G.;Pirozzi, G.;Fontana, S.;Zappacosta, S.;La Cava, A.;Matarese, G. A key role of leptin in the control of regulatory T cell proliferation. Immunity, 2007, 26(2), 241-255.
67. Procaccini, C.;De Rosa, V.;Galgani, M.;Abanni, L.;Cali, G.;Porcellini, A.;Carbone, F.;Fontana, S.;Horvath, T.L.;La Cava, A.;Matarese, G. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity, 2010, 33(6), 929-941.
68. Toussirot, E.;Streit, G.;Nguyen, N.U.;Dumoulin, G.;Le Huede, G.;Saas, P.;Wendling, D. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism, 2007, 56(10), 1383-1389.
69. Vuolteenaho, K.;Koskinen, A.;Kukkonen, M.;Nieminen, R.;Paivarinta, U.;Moilanen, T.;Moilanen, E. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage - mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm., 2009, 2009, 345838.
70. Mutabaruka, M.S.;Aoulad Aissa, M.;Delalandre, A.;Lavigne, M.;Lajeunesse, D. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis. Res. Ther., 2010, 12(1), R20.
71. Karvonen-Gutierrez, C.A.;Harlow, S.D.;Mancuso, P.;Jacobson, J.;de Leon, C.F.;Nan, B. Leptin levels are associated with radiographic knee osteoarthritis among a cohort of mid-life women. Arthritis. Care Res. (Hoboken), 2013, 65(6), 936-944.
72. Griffin, T.M.;Huebner, J.L.;Kraus, V.B.;Guilak, F. Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum., 2009, 60(10), 2935-2944.
73. de Boer, T.N.;van Spil, W.E.;Huisman, A.M.;Polak, A.A.;Bijlsma, J.W.;Lafeber, F.P.;Mastbergen, S.C. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage, 2012, 20(8), 846-853.
74. Oliveria, S.A.;Felson, D.T.;Cirillo, P.A.;Reed, J.I.;Walker, A.M. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology, 1999, 10(2), 161-166.
75. Yusuf, E.;Nelissen, R.G.;Ioan-Facsinay, A.;Stojanovic-Susulic, V.;DeGroot, J.;van Osch, G.;Middeldorp, S.;Huizinga, T.W.;Kloppenburg, M. Association between weight or body mass index and hand osteoarthritis: a systematic review. Ann. Rheum. Dis., 2010, 69(4), 761-765.
76. Massengale, M.;Lu, B.;Pan, J.J.;Katz, J.N.;Solomon, D.H. Adipokine hormones and hand osteoarthritis: radiographic severity and pain. PLoS One, 2012, 7(10), 47860.
77. Yusuf, E.;Ioan-Facsinay, A.;Bijsterbosch, J.;Klein-Wieringa, I.;Kwekkeboom, J.;Slagboom, P.E.;Huizinga, T.W.;Kloppenburg, M. Association between leptin, adiponectin and resistin and longterm progression of hand osteoarthritis. Ann. Rheum. Dis., 2011, 70(7), 1282-1284.
78. Liu, S.Q.;Wu, J.;Mo, J.;Sun, Z.X.;Yang, H.B.;Huang, C.W.;Lei, M.X.;Peng, L.W.;Xu, L. [Serum leptin level and its association with bone mineral density in obese children]. Zhongguo Dang Dai Er Ke Za Zhi, 2009, 11(9), 745-748.
79. Reid, I.R. Obesity and osteoporosis. Ann. Endocrinol. (Paris), 2006, 67(2), 125-129.
80. Silva, H.G.;Mendonca, L.M.;Conceicao, F.L.;Zahar, S.E.;Farias, M.L. Influence of obesity on bone density in postmenopausal women. Arq. Bras. Endocrinol. Metabol., 2007, 51(6), 943-949.
81. Albala, C.;Yanez, M.;Devoto, E.;Sostin, C.;Zeballos, L.;Santos, J.L. Obesity as a protective factor for postmenopausal osteoporosis. Int. J. Obes. Relat. Metab. Disord., 1996, 20(11), 1027-1032.
82. Zhao, L.J.;Liu, Y.J.;Liu, P.Y.;Hamilton, J.;Recker, R.R.;Deng, H.W. Relationship of obesity with osteoporosis. J. Clin. Endocrinol. Metab., 2007, 92(5), 1640-1646.
83. Zhao, L.J.;Jiang, H.;Papasian, C.J.;Maulik, D.;Drees, B.;Hamilton, J.;Deng, H.W. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J. Bone Miner. Res., 2008, 23(1), 17-29.
84. Migliaccio, S.;Greco, E.A.;Fornari, R.;Donini, L.M.;Lenzi, A. Is obesity in women protective against osteoporosis? Diabetes Metab. Syndr. Obes., 2011, 4, 273-282.
85. Bjornholm, M.;Munzberg, H.;Leshan, R.L.;Villanueva, E.C.;Bates, S.H.;Louis, G.W.;Jones, J.C.;Ishida-Takahashi, R.;Bjorbaek, C.;Myers, M.G., Jr. Mice lacking inhibitory leptin receptor signals are lean with normal endocrine function. J. Clin. Invest., 2007, 117(5), 1354-1360.
86. Shi, Y.;Yadav, V.K.;Suda, N.;Liu, X.S.;Guo, X.E.;Myers, M.G., Jr.;Karsenty, G. Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc. Natl. Acad. Sci. U S A, 2008, 105(51), 20529-20533.
87. Fujita, Y.;Watanabe, K.;Maki, K. Serum leptin levels negatively correlate with trabecular bone mineral density in high-fat dietinduced obesity mice. J. Musculoskelet. Neuronal. Interact., 2012, 12(2), 84-94.
88. Fisher, A.;Srikusalanukul, W.;Davis, M.;Smith, P. Interactions between Serum Adipokines and Osteocalcin in Older Patients with Hip Fracture. Int. J. Endocrinol., 2012, 2012, 684323.
89. Farooqi, I.S.;Jebb, S.A.;Langmack, G.;Lawrence, E.;Cheetham, C.H.;Prentice, A.M.;Hughes, I.A.;McCamish, M.A.;O'Rahilly, S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N. Engl. J. Med., 1999, 341(12), 879-884.
90. Oral, E.A.;Simha, V.;Ruiz, E.;Andewelt, A.;Premkumar, A.;Snell, P.;Wagner, A.J.;DePaoli, A.M.;Reitman, M.L.;Taylor, S.I.;Gorden, P.;Garg, A. Leptin-replacement therapy for lipodystrophy. N. Engl. J. Med., 2002, 346(8), 570-578.
91. Roth, J.D.;Roland, B.L.;Cole, R.L.;Trevaskis, J.L.;Weyer, C.;Koda, J.E.;Anderson, C.M.;Parkes, D.G.;Baron, A.D. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc. Natl. Acad. Sci. U S A, 2008, 105(20), 7257-7262.
92. Ravussin, E.;Smith, S.R.;Mitchell, J.A.;Shringarpure, R.;Shan, K.;Maier, H.;Koda, J.E.;Weyer, C. Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy. Obesity (Silver Spring), 2009, 17(9), 1736-1743.